2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
As digitalization expands across the regulatory value chain, global collaboration when regulating advanced technology use in drug development has become more critical than ever.
During the first international symposium on the use of AI in medical products, co-hosted by US and Korean regulators, global experts discussed issues and challenges related to effective development and regulation. Cooperation, flexibility and the need for a "human-centric" approach emerged as key themes in the fast-moving field.
India’s drugs regulator sets out plans for extensive digitization across the regulatory value chain and regulatory rationalization initiatives, while also “looking inward” to up its game as it tightens processes and enforcement. Audit action under the revised GMP norms is also being kicked off.
